You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Drugs with Dosage: BAR


✉ Email this page to a colleague

« Back to Dashboard


Drugs with Dosage: BAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
Parke Davis CHOLYBAR cholestyramine BAR, CHEWABLE;ORAL 071621-001 May 26, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up BAR, CHEWABLE;ORAL
Parke Davis CHOLYBAR cholestyramine BAR, CHEWABLE;ORAL 071739-001 May 26, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up BAR, CHEWABLE;ORAL
Cosette WELCHOL colesevelam hydrochloride BAR, CHEWABLE;ORAL 210895-001 Apr 3, 2019 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up BAR, CHEWABLE;ORAL
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration >Dosage

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.